Nanocarriers for the Delivery of Combination Drugs

Nanocarriers for the Delivery of Combination Drugs focuses on the role of nanocarriers in the delivery of combination drugs for the management and treatment of various diseases. Combination drug therapy success has been limited due to the inability of the individual drugs to achieve the desired therapeutic outcome when they are delivered in the individual form and reasons for this can be the difference in physiochemical and biopharmaceutical characteristics of drugs leading to variable results.

Nanocarriers have been used for the co-delivery of drug combinations for delivering drugs at the right place and right time in combinations. Nanocarriers belonging to the category of polymeric nanoparticles, dendrimers, lipidic nanocarriers like nanoemulsions, liposomes, solid lipid nanoparticles, nanostructured lipid carriers, are now being used for drug delivery of combination drugs.

The primary focus of Nanocarriers for the Delivery of Combination Drugs is to assimilate all the information available pertaining to the application of various nanocarrier technology for the delivery of combination drugs of synthetic and natural origin and encompassing small and large molecules. It is an important reference source for pharmaceutical scientists and biomaterials scientists, who are looking to gain an increased understanding of how nanotechnology is improving the efficiency of combination drug delivery.